Intra-Cellular Therapies Statistics
Total Valuation
Ambarella has a market cap or net worth of EUR 2.34 billion. The enterprise value is 2.12 billion.
Market Cap | 2.34B |
Enterprise Value | 2.12B |
Important Dates
The next estimated earnings date is Tuesday, August 26, 2025.
Earnings Date | Aug 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 42.41M |
Shares Outstanding | n/a |
Shares Change (YoY) | +3.55% |
Shares Change (QoQ) | +0.93% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 39.88M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 9,072.06 |
PS Ratio | 8.40 |
PB Ratio | 4.64 |
P/TBV Ratio | 11.85 |
P/FCF Ratio | 53.37 |
P/OCF Ratio | 41.78 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -23.24 |
EV / Sales | 7.74 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 48.34 |
Financial Position
The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.01.
Current Ratio | 2.69 |
Quick Ratio | 2.32 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | 0.09 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.35% and return on invested capital (ROIC) is -12.42%.
Return on Equity (ROE) | -18.35% |
Return on Assets (ROA) | -10.54% |
Return on Invested Capital (ROIC) | -12.42% |
Return on Capital Employed (ROCE) | -19.58% |
Revenue Per Employee | 296,233 |
Profits Per Employee | -96,965 |
Employee Count | 941 |
Asset Turnover | 0.47 |
Inventory Turnover | 3.71 |
Taxes
Income Tax | -630,201 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.61% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +25.61% |
50-Day Moving Average | 53.20 |
200-Day Moving Average | 57.49 |
Relative Strength Index (RSI) | 51.91 |
Average Volume (20 Days) | 60 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.28 |
Income Statement
In the last 12 months, Ambarella had revenue of EUR 278.76 million and -91.24 million in losses. Loss per share was -2.20.
Revenue | 278.76M |
Gross Profit | 168.09M |
Operating Income | -99.61M |
Pretax Income | -91.87M |
Net Income | -91.24M |
EBITDA | -87.92M |
EBIT | -99.61M |
Loss Per Share | -2.20 |
Balance Sheet
The company has 228.62 million in cash and 3.87 million in debt, giving a net cash position of 224.75 million.
Cash & Cash Equivalents | 228.62M |
Total Debt | 3.87M |
Net Cash | 224.75M |
Net Cash Per Share | n/a |
Equity (Book Value) | 504.79M |
Book Value Per Share | 11.90 |
Working Capital | 185.71M |
Cash Flow
In the last 12 months, operating cash flow was 56.05 million and capital expenditures -12.18 million, giving a free cash flow of 43.87 million.
Operating Cash Flow | 56.05M |
Capital Expenditures | -12.18M |
Free Cash Flow | 43.87M |
FCF Per Share | n/a |
Margins
Gross margin is 60.30%, with operating and profit margins of -35.73% and -32.73%.
Gross Margin | 60.30% |
Operating Margin | -35.73% |
Pretax Margin | -32.96% |
Profit Margin | -32.73% |
EBITDA Margin | -31.54% |
EBIT Margin | -35.73% |
FCF Margin | 15.74% |
Dividends & Yields
Ambarella does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.55% |
Shareholder Yield | n/a |
Earnings Yield | -3.90% |
FCF Yield | 1.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Ambarella has an Altman Z-Score of 11.01 and a Piotroski F-Score of 3.
Altman Z-Score | 11.01 |
Piotroski F-Score | 3 |